Gender identity in XY intersexuality

Child and Adolescent Psychiatric Clinics of North America

Volumn 13, Issue 3, 2004, Pages 609-622

  Sobel, Vivian ^a   Imperato McGinley, Julianne ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE 3; 5ALPHA REDUCTASE 2; ESTROGEN; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

ANDROGEN INSENSITIVITY SYNDROME; BREAST DEVELOPMENT; ESTROGEN THERAPY; FETUS DEVELOPMENT; GENDER IDENTITY; GENE MUTATION; GYNECOMASTIA; HERMAPHRODITISM; HUMAN; MASCULINITY; MENSTRUATION; ORCHIECTOMY; PHENOTYPE; PLASTIC SURGERY; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SEXUAL BEHAVIOR; SPERMATOGENESIS;

EID: 2942535863     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2004.02.014     Document Type: Review

References (63)

1. Imperato-McGinley J., Gerrero L., Gautier T., et al. Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 186:1974;1213-1215
2. Walsh P.C., Madden J.D., Harrod M.J. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med. 291:1974;944-949
3. Fratianni C.M., Imperato-McGinley J. The syndrome of 5α-reductase deficiency. Endocrinologist. 4:1994;302-314
4. Imperato-McGinley J., Peterson R.E., Gautier T., et al. Male pseudohermaphroditism secondary to 5α-reductase deficiency- a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity. J Steroid Biochem. 11:1979;637-645
5. Imperato-McGinley J., Peterson R.E., Gautier T., et al. Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5α-reductase deficiency. N Engl J Med. 300:1979;1233-1237
6. Akgun S., Ertel N.H., Imperato-McGinley J., et al. Familial male pseudohermaphroditism due to 5α-reductase deficiency in a Turkish village. Am J Med. 81:1986;267-274
7. Can S., Zhu Y.-S., Cai L.-Q., et al. The identification of 5α-reductase-2 and 17β- hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred. J Clin Endocrinol Metab. 83:1998;560-569
8. Imperato-McGinley J., Miller M., Wilson J.D., et al. A cluster of male pseudohermaphrodites with 5α-reductase deficiency in Papua New Guinea. Clin Endocrinol (Oxf). 34:1991;293-298
9. Zhu Y.S., Katz M.D., Imperato-McGinley J. Natural potent androgens: lessons from human genetic models. Baillieres Clin Endocrinol Metab. 12:1998;83-113
10. Schwartz J.I., Tanaka W.K., Wang D.Z., et al. MK-386, an inhibitor of 5α-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen. J Clin Endocrinol Metab. 82:1997;1373-1377
11. Imperato-McGinley J., Zhu Y.-S. Androgens and male physiology the syndrome of 5α-reductase-2 deficiency. Mol Cell Endocrinol. 198:2002;51-59
12. Imperato-McGinley J., Peterson R.E., Gautier T., et al. The impact of androgens on the evolution of male gender identity. Kogan S.J., Hafez E.S. Pediatric andrology. 1981;125-140 Kluwer, Hingham (MA)
13. Gadjusek D.C. Congenital absence of the penis in Muniri and Simbari Kukulkuku people of New Guinea. Presented at the 74th Meeting of the American Pediatric Society. Seattle, June 16-18, 1964
14. Gadjusek D.C. Urgent opportunistic observations: the study of changing, transient and disappearing phenomena of medical interest in disrupted primitive human communities. Health and disease in tribal societies. 1977;69-102 Elsevier Excerpta Medica North Holland and Elsevier North Holland, Inc. Amsterdam
15. Gadjusek D.C. Journals 1957-76. Eighteen volumes (with specified field data on Simbari male pseudohermaphrodites). 1959-1989;National Institutes of Health, Bethesda
16. Herdt G.H., Davidson J. The Sambia "turnim-man": sociocultural and clinical aspects of gender formation in male pseudohermaphrodites with 5α-reductase deficiency in Papua, New Guinea. Arch Sex Behav. 17:1988;33-56
17. Mendonca B.B., Inacio M., Costa E.M.F., et al. Male pseudohermaphroditism due to steroid 5α-reductase 2 deficiency, diagnosis, psychological evaluation and management. Medicine. 75:1996;64-76
18. Mendez J.P., Ulloa-Aguirre A., Imperato-McGinley J., et al. Male pseudohermaphroditism due to primary 5α-reductase deficiency: variation in gender identity reversal in seven Mexican patients from five different pedigrees. J Endocrinol Invest. 18:1995;205-213
19. Canto P., Vilchis F., Chavez B., et al. Mutations of the 5α-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5α-reductase-2 deficiency. Clin Endocrinol (Oxf). 46:1997;155-160
20. Price P., Wass J.A.H., Griffin J.E., et al. High dose androgen therapy in male pseudohermaphroditism due to 5α-reductase deficiency and disorders of the androgen receptor. J Clin Invest. 74:1984;1496-1508
21. Mulaisho C., Taha S.A., Imperato-McGinley J. Male pseudohermaphroditism due to deficiency of steroid 5α-reductase enzyme. Saudi Med J. 11:1990;71-73
22. Kuttenn F., Mowsozowicz I., Wright F., et al. Male pseudohermaphroditism: a comparative study of one patient with 5α-reductase deficiency and three patients with the complete form of testicular feminization. J Clin Endocrinol Metab. 49:1979;861-865
23. Savage M.O., Preece M.A., Jeffcoate S.L., et al. Familial male pseudohermaphroditism due to deficiency of 5α-reductase. Clin Endocrinol (Oxf). 12:1980;397-406
24. Al-Attia H.M., Kazim S., George S. 5α-reductase deficiency in two Omani siblings. Emirates Med J. 5:1987;236-242
25. Al-Attia H.M. Gender identity and role in a pedigree of Arabs with intersex due to 5α-reductase-2 deficiency. Psychoneuroendocrinology. 21:1996;651-657
26. Hochberg Z., Chayen R., Reiss N., et al. Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5α-reductase 2 deficiency. J Clin Endocrinol Metab. 81:1996;2821-2827
27. Money J., Ehrhardt A.A. Man and woman, boy and girl: the differentiation and dimorphism of gender identity from conception to maturity. 1972;Johns Hopkins University Press, Baltimore (MD)
28. Imperato-McGinley J., Peterson R.E., Leshin M. Steroid 5α-reductase deficiency in a 65-year-old male pseudohermaphrodite: the natural history, ultrastructure of the testes, and evidence for inherited enzyme heterogeneity. J Clin Endocrinol Metab. 50:1980;15-22
29. Carpenter T.O., Imperato-McGinley J., Boulware S.D., et al. Variable expression of 5α-reductase deficiency: presentation with male phenotype in a child of Greek origin. J Clin Endocrinol Metab. 71:1990;318-322
30. Katz M.D., Kligman I., Cal L.-Q., et al. Paternity by intrauterine insemination with sperm from a man with 5α-reductase-2 deficiency. N Engl J Med. 336:1997;994-997
31. Nordenskjold A., Ivarsson S.-A. Molecular characterization of 5α-reductase type 2 deficiency and fertility in a Swedish family. J Clin Endocrinol Metab. 83:1998;3236-3238
32. Ivarsson S.-A. 5α-reductase deficient men are fertile. Eur J Pediatr. 155:1996;425
33. Andersson S., Russell D.W., Wilson J.D. 17β-hydroxysteroid dehydrogenase 3 deficiency. Trends Endocrinol Metab. 7:1996;121-126
34. Saez J.M., de Peretti E., Morera A.M., et al. Familial male pseudohermaphroditism with gynecomastia due to testicular 17-ketoreductase defect. J Clin Endocrinol Metab. 32:1971;604-610
35. Rosler A., Kohn G. Male pseudohermaphroditism due to 17β- hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role. J Steroid Biochem. 19:1983;663-674
36. Rosler A., Silverstein S., Abeliovich D. A (R80Q) mutation in 17β-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab. 81:1996;1827-1831
37. Diamond M. Pediatric management of ambiguous and traumatized genitalia. J Urol. 162:1999;1021-1028
38. Gross D.J., Landau H., Kohn G. Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency: gender reassignment in early infancy. Acta Endocrinol (Copenh). 112:1986;238-246
39. Farkas A., Rosler A. Ten years experience with masculinizing genitoplasty in male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase deficiency. Eur J Pediatr. 152:1993;S88-S90
40. Imperato-McGinley J., Akgun S., Ertel N.H., et al. The coexistence of male pseudohermaphrodites with 17-ketosteroid reductase deficiency and 5α-reductase deficiency within a Turkish kindred. Clin Endocrinol (Oxf). 27:1987;135-143
41. Akesode F.A., Meyer W.J. III, Migeon C.J. Male pseudohermaphroditism with gynaecomastia due to testicular 17-ketosteroid reductase deficiency. Clin Endocrinol (Oxf). 7:1977;443-452
42. Imperato-McGinley J., Peterson R.E., Stoller R., et al. Male pseudohermaphroditism secondary to 17β-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J Clin Endocrinol Metab. 49:1979;391-395
43. Lanes R., Brown T.R., Gruber de Bustos E., et al. Sibship with l7-ketosteroid reductase (17-KSR) deficiency and hypothyroidism. Lack of linkage of histocompatibility leukocyte antigen and 17-KSR loci. J Clin Endocrinol Metab. 57:1983;190-196
44. Stoller R.J. A contribution to the study of gender identity. Int J Psychoanal. 45:1964;220-226
45. Imperato-McGinley J., Zhu Y.-S. Gender and behavior in subjects with genetic defects in male sexual differentiation. Pfaff D.W., Arnold A.P., Etgen A.M., Fahrbach S.E., Rubin R.T. Hormones, brain and behavior. volume 5:2002;303-345 Elsevier Science, San Diego (CA)
46. Mendonca B.B., Inacio M., Arnhold I.J.P., et al. Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase 3 deficiency, diagnosis, psychological evaluation and management. Medicine. 79:2000;299-309
47. Givens J.R., Wiser W.L., Summitt R.L., et al. Familial male pseudohermaphroditism without gynecomastia due to deficient testicular 17-ketosteroid reductase activity. N Engl J Med. 291:1974;938-944
48. Perez-Palacios G., Chavez B., Mendez J.P., et al. The syndromes of androgen resistance revisited. J Steroid Biochem. 27:1987;1101-1108
49. Sultan C., Lumbroso S., Paris F., et al. Disorders of androgen action. Sem Repro Med. 20:2002;217-227
50. Vague J. Testicular feminization syndrome, an experimental model for the study of hormone action on sexual behavior. Horm Res. 18:1983;62-68
51. Melo K.F.S., Mendonca B.B., Billerbeck A.E.C., et al. Clinical, hormonal, behavioral and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J Clin Endocrinol Metab. 88:2003;3241-3250
52. Masica D.N., Money J.M., Ehrhardt A.A. Fetal feminization and female gender identity in the testicular feminizing syndrome of androgen insensitivity. Arch Sex Behav. 1:1971;131-142
53. Wisniewski A.B., Migeon C.J., Meyer-Bahlburg H.F.L., et al. Complete androgen insensitivity syndrome: long term medical, surgical, and psychosexual outcome. J Clin Endocrinol Metab. 85:2000;2664-2669
54. Hines M., Ahmed S.F., Hughes I.A. Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch Sex Behav. 32:2003;93-101
55. Wisniewski A.B., Migeon C.J. Long-term perspectives for 46, XY patients affected by complete androgen insensitivity syndrome or congenital micropenis. Semin Reproduct Med. 20:2002;297-304
56. Rodien P., Mebarki F., Mowszowicz I., et al. Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metab. 81:1996;2994-2998
57. Wilson J.D., Harrod M.J., Goldstein J.L., et al. Familial incomplete male pseudohermaphroditism, type 1. Evidence for androgen resistance and variable clinical manifestations in a family with Reifenstein syndrome. N Engl J Med. 290:1974;1097-1103
58. Boehmer A.L.M., Bruggenwirth H., Van Assendelft C., et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab. 86:2001;4151-4160
59. Gooren L., Cohen-Kettenis P.T. Development of a male gender identity/role and a sexual orientation towards women in a 46, XY subject with an incomplete form of the androgen insensitivity syndrome. Arch Sex Behav. 20:1991;459-470
60. Diamond M., Sigmundson K. Management of intersexuality: guidelines for dealing with persons with ambiguous genitalia. Arch Pediatr Adolesc Med. 151:1997;1046-1050
61. Quigley C., De Bellis A., Merschke K.B., et al. Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev. 16:1995;271-321
62. Reiner W.G., Gearhart J.P. Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth. N Engl J Med. 350:2004;333-341
63. Kipnis K, Diamond M. Pediatric ethics and the surgical assignment of sex. J Clin Ethics 1998;9:398- 410.